Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Liminal Biosciences Inc (LMNL)

Liminal Biosciences Inc (LMNL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 87,736
  • Shares Outstanding, K 29,944
  • Annual Sales, $ 2,480 K
  • Annual Income, $ -88,030 K
  • 60-Month Beta 1.79
  • Price/Sales 35.56
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade LMNL with:

Options Overview

Details
  • Implied Volatility 94.71%
  • Historical Volatility 59.15%
  • IV Percentile 8%
  • IV Rank 10.10%
  • IV High 279.84% on 06/04/21
  • IV Low 73.91% on 04/07/21
  • Put/Call Vol Ratio 0.06
  • Today's Volume 36
  • Volume Avg (30-Day) 66
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 2,647
  • Open Int (30-Day) 3,644

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.44
  • Number of Estimates 2
  • High Estimate -0.35
  • Low Estimate -0.53
  • Prior Year -0.86
  • Growth Rate Est. (year over year) +48.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.84 +4.23%
on 07/28/21
3.96 -25.25%
on 07/12/21
-0.91 (-23.51%)
since 07/02/21
3-Month
2.84 +4.23%
on 07/28/21
6.30 -53.02%
on 06/07/21
-2.07 (-41.15%)
since 04/30/21
52-Week
2.84 +4.23%
on 07/28/21
21.29 -86.10%
on 08/03/20
-13.35 (-81.85%)
since 07/31/20

Most Recent Stories

More News
Liminal BioSciences Inc. (LMNL) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Liminal BioSciences Inc. (LMNL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LMNL : 2.96 (+1.02%)
Liminal BioSciences Announces Closing of Sale of Plasma-Derived Therapeutics Manufacturing Facility

and , /PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, announced today that it has closed on the previously...

LMNL : 2.96 (+1.02%)
Liminal BioSciences Announces Signature of a Share Purchase Agreement for sale of Remaining Plasma-derived Business with Kedrion

and , /PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced today that, Kedrion S.p.A ("Kedrion") has exercised its option to acquire the remainder...

LMNL : 2.96 (+1.02%)
Company News for Jun 8, 2021

Companies in the news are: GIII, USCR, LMNL, BIIB

BIIB : 331.70 (+1.52%)
GIII : 29.76 (-0.33%)
USCR : 72.95 (+0.19%)
LMNL : 2.96 (+1.02%)
Thinking about buying stock in BioNano Genomics, RA Medical Systems, Microvision, Liminal BioSciences, or Clover Health?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BNGO, RMED, MVIS, LMNL, and CLOV.

BNGO : 6.03 (+1.69%)
CLOV : 8.15 (+0.99%)
LMNL : 2.96 (+1.02%)
MVIS : 13.58 (-1.38%)
RMED : 4.07 (+18.66%)
Liminal Announces Voting Results of Its 2021 Annual and Special General Meeting of Shareholders (AGM)

and , /PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company") announced the voting results from its Annual General and Special Meeting of Shareholders ("AGM")...

LMNL : 2.96 (+1.02%)
Liminal BioSciences Announces FDA Approval for its Biologics License Application for Ryplazimœ (plasminogen, human-tvmh)

and , /PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company") announced today that the U.S. Food & Drug Administration (FDA) has approved Ryplazim (plasminogen,...

LMNL : 2.96 (+1.02%)
Liminal BioSciences Provides an Update on Currently Planned Clinical Activities for Fezagepras

and , /PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, announced today that based on interim pharmacokinetic...

LMNL : 2.96 (+1.02%)
Liminal BioSciences Announces Closing of Divestiture of Plasma Collection Centers and Enters into Option Agreement with Kedrion

and , /PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, announced today that it has closed on the previously...

LMNL : 2.96 (+1.02%)
Liminal BioSciences Reports First Quarter 2021 Financial Results

Liminal will host a conference call at May 18, 2021. The telephone numbers to access the conference call are 1-888-390-0605 and 416-764-8609. An audio replay of the call will be available as of at ....

LMNL : 2.96 (+1.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Liminal BioSciences Inc. is a biotechnology company. It engages in discovering, developing and commercializing novel small molecule compounds for respiratory, liver and renal diseases. The company's product pipeline consists of PBI-4050, which are in clinical stage. Liminal BioSciences Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 3.11
2nd Resistance Point 3.07
1st Resistance Point 3.01
Last Price 2.96
1st Support Level 2.91
2nd Support Level 2.87
3rd Support Level 2.81

See More

52-Week High 21.29
Fibonacci 61.8% 14.24
Fibonacci 50% 12.07
Fibonacci 38.2% 9.89
Last Price 2.96
52-Week Low 2.84

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar